Patrick Trucchio

H.C. Wainwright & Co.

Recent Articles about Alto Neuroscience Inc.

2 Key Catalysts Ahead for Developer of Psych Drugs 10/28/2025

Alto Neuroscience Inc. (ANRO:NYSE) expects to release topline trial data in 2025 and commence a separate study in 2026, noted an H.C. Wainwright & Co. report.